Findings

What do systematic reviews say?

7 questions · 8 findings · 4 reviews · Haematology

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 75%GRADE not reported 2 · 25%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Casirivimab/imdevimab vs placebo

Quality of life at longest · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2

The review found no eligible studies for this question.

2 findings from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bamlanivimab vs placebo

Quality of life at longest · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2

The review found no eligible studies for this question.

1 finding from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tixagevimab/cilgavimab vs placebo

Quality of life at longest · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2

The review found no eligible studies for this question.

1 finding from 1 review

SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Azithromycin vs placebo or usual care

Quality of life at longest · all trials contributing results to the summary of findings table included people with mild disease (WHO scale 1 to 3)§

1 finding from 1 review

Antibiotics for the treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Azithromycin vs placebo or usual care

Quality of life at longest · people with moderate to severe disease (WHO scale 4–9); all studies contributing results to the summary of findings table included people…

1 finding from 1 review

Antibiotics for the treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Fluvoxamine plus standard care vs placebo + standard care

Quality of life at longest · symptomatic people with COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Fluvoxamine for the treatment of COVID‐19 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Colchicine plus standard care vs placebo or usual care

Quality of life, including fatigue and neurological functioning; · individuals with moderate or severe COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Colchicine for the treatment of COVID‐19 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found